dr. jeffrey weber explores nivolumab in advanced melanoma
Published 11 years ago • 1.1K plays • Length 2:05Download video MP4
Download video MP3
Similar videos
-
1:22
dr. weber on nivolumab versus chemotherapy in advanced melanoma
-
2:18
dr. jeffrey weber on checkmate-064 trial for advanced melanoma
-
1:15
dr. weber on nivolumab in the adjuvant setting for melanoma
-
1:28
dr. jeffery s. weber on sequencing of nivolumab, ipilimumab in metastatic melanoma
-
1:44
dr. jeffrey weber on optimal therapy sequences in advanced melanoma
-
1:55
dr. jeffrey weber on ipilimumab for melanoma
-
0:49
dr. weber on emerging therapies in melanoma
-
1:24
dr. ernstoff discusses nivolumab and ipilimumab in advanced melanoma
-
2:26
jeffrey weber, md, phd explains the long term data from keynote-001 study in advanced melanoma
-
2:10
dr. weber on the toxicity profile of nivolumab versus ipilimumab for melanoma
-
1:22
dr. weber on adjuvant pembrolizumab in melanoma
-
2:25
dr. weber on discontinuing immunotherapy in melanoma
-
1:21
dr. jeffrey weber on potential breakthrough "cures" in melanoma
-
1:14
dr. weber discusses advancements in melanoma
-
1:08
dr. weber discusses toxicity of immunotherapies in melanoma
-
2:22
adjuvant nivolumab in patents with high-risk resected melanoma
-
1:03
dr. weber on risk and benefits with immunotherapy combos in melanoma
-
7:34
adjuvant therapy for melanoma: nivolumab, pembrolizumab, ipilimumab, dabrafenib and trametinib
-
1:34
fda approves frontline nivolumab for advanced melanoma